Cargando…
Isocitrate dehydrogenase variants in cancer — Cellular consequences and therapeutic opportunities
Abnormal metabolism is common in cancer cells and often correlates with mutations in genes encoding for enzymes involved in small-molecule metabolism. Isocitrate dehydrogenase 1 (IDH1) is the most frequently mutated metabolic gene in cancer. Cancer-associated substitutions in IDH1 and IDH2 impair wi...
Autores principales: | Liu, Shuang, Cadoux-Hudson, Tom, Schofield, Christopher J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487778/ https://www.ncbi.nlm.nih.gov/pubmed/32777735 http://dx.doi.org/10.1016/j.cbpa.2020.06.012 |
Ejemplares similares
-
Isocitrate dehydrogenase gene variants in cancer and their clinical significance
por: Cadoux-Hudson, Thomas, et al.
Publicado: (2021) -
Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations
por: Hvinden, Ingvild Comfort, et al.
Publicado: (2021) -
Roles of metal ions in the selective inhibition of oncogenic variants of isocitrate dehydrogenase 1
por: Liu, Shuang, et al.
Publicado: (2021) -
Differentiating
Inhibition Selectivity and Binding
Affinity of Isocitrate Dehydrogenase 1 Variant Inhibitors
por: Liu, Shuang, et al.
Publicado: (2023) -
Isocitrate dehydrogenase mutations: new opportunities for translational research
por: Keum, Young-Sam, et al.
Publicado: (2015)